These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37199768)

  • 21. Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study.
    Lin CW; Huang WI; Chao PH; Chen WW; Hsiao FY
    Epilepsia; 2018 Dec; 59(12):2325-2339. PubMed ID: 30479027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.
    Kim JY; Lee J; Ko YJ; Shin JY; Jung SY; Choi NK; Park BJ
    PLoS One; 2013; 8(12):e83849. PubMed ID: 24391836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
    Hung SI; Chung WH; Jee SH; Chen WC; Chang YT; Lee WR; Hu SL; Wu MT; Chen GS; Wong TW; Hsiao PF; Chen WH; Shih HY; Fang WH; Wei CY; Lou YH; Huang YL; Lin JJ; Chen YT
    Pharmacogenet Genomics; 2006 Apr; 16(4):297-306. PubMed ID: 16538176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
    Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
    Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Rigby A; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; (12):CD007124. PubMed ID: 25470302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy.
    Garg VK; Goyal MK; Khullar M; Saikia B; Medhi B; Prakash A; Prabhat N; Tandyala N; Mahesh KV; Kharbanda PS; Prabhakar S; Modi M; Lal V; Shree R; Sachdeva J
    Indian J Pharmacol; 2020; 52(5):378-382. PubMed ID: 33283769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.
    Hu FY; Wang W; Ren JC; An DM; Chen JN; Zhou D
    Epilepsy Res; 2016 Aug; 124():12-5. PubMed ID: 27162008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.
    Kim SH; Lee KW; Song WJ; Kim SH; Jee YK; Lee SM; Kang HR; Park HW; Cho SH; Park SH; Min KU; Chang YS;
    Epilepsy Res; 2011 Nov; 97(1-2):190-7. PubMed ID: 21917426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamazepine-induced cutaneous reactions: a simple assay to identify patients carrying the HLA-A*31:01 allele.
    Thorstensen K; Kvitland M; Shirzadi M; Helde G; Moen T; Brodtkorb E
    Scand J Clin Lab Invest; 2014 Oct; 74(7):644-7. PubMed ID: 24882392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Rigby A; Marson AG
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007124. PubMed ID: 27933615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.
    Grover S; Kukreti R
    Pharmacogenet Genomics; 2014 Feb; 24(2):94-112. PubMed ID: 24336023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.
    Yip VL; Marson AG; Jorgensen AL; Pirmohamed M; Alfirevic A
    Clin Pharmacol Ther; 2012 Dec; 92(6):757-65. PubMed ID: 23132554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy.
    Plumpton CO; Yip VL; Alfirevic A; Marson AG; Pirmohamed M; Hughes DA
    Epilepsia; 2015 Apr; 56(4):556-63. PubMed ID: 26046144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
    Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
    Kay L; Willems LM; Zöllner JP; Reif PS; Klein KM; Rosenow F; Strzelczyk A
    Seizure; 2017 Apr; 47():81-82. PubMed ID: 28340402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.